# Qinecsa CEO featured in the Molecule to Market podcast

- Articles, Resources  
- July 25, 2025

_Molecule to Market_ is a podcast focused on the pharmaceutical and biotech industries, particularly the outsourcing and supply chain side of drug development. Hosted by Raman Sehgal, the show features interviews with industry leaders, entrepreneurs, and experts who share insights into how drugs go from initial molecule discovery all the way to market.

Qinecsa CEO Adam Sherlock joins this episode to share his insights from nearly four decades in the life sciences industry. From pharma and IVD to medtech and biotech, Adam brings a seasoned, no-nonsense perspective on what drives value in the pharma services space.

In this episode, they explore:

🔹 How timing, gut instinct, and market dynamics shape M&A success  
🔹 The moments when it is the right time to go to market or walk away  
🔹 Why collaboration beats competition, and how the best deals are often built on trust  
🔹 How [AI is set to transform R&D](/content/insights/powering-the-pharmacovigilance-engine-why-ais-role-is-pivotal-now/index.html) services and why we all need to “eat our own lunch”

Packed with industry-specific takeaways, this episode is a must-listen for professionals across drug development and pharmacovigilance.

##### Listen now:  [Spotify](https://open.spotify.com/episode/5KGBckckbA0eHuDaxE9hAm)  [Apple](https://podcasts.apple.com/gb/podcast/40-years-6-exits-a-ceo-addict/id1509290866?i=1000718960599)  [Amazon](https://music.amazon.co.uk/podcasts/cedfb869-cea1-43ff-824d-50607420ae3b/episodes/2d80e86f-1d2b-43dd-b669-505c49adb293/molecule-to-market-inside-the-outsourcing-space-40-years-6-exits---a-ceo-addict)

## Recent Articles

### [The Productivity Crisis That Persists Even Now: What Will It Take to Free Up PV Professionals to Assess Safety, Rather Than Coordinate Data?](/content/resources/the-productivity-crisis-that-persists-even-now-what-will-it-take-to-free-up-pv-professionals-to-assess-safety-rather-than-coordinate-data/index.html)

- July 28, 2026

### [Embracing quantitative signal detection methods as a smaller MAH](/content/resources/embracing-quantitative-signal-detection-methods-as-a-smaller-mah/index.html)

- June 25, 2026

### [Real-Time Safety Signals Drive Continuous PV Insight](/content/articles/real-time-safety-signals-drive-continuous-pv-insight/index.html)

- May 27, 2026

### [From Complaint Handling to Active Surveillance](/content/resources/from-complaint-handling-to-active-surveillance/index.html)

- May 5, 2026

### [Continuous Safety Surveillance for Medical Devices](/content/resources/continuous-safety-surveillance-for-medical-devices/index.html)

- May 5, 2026

### [Are patient outcomes getting lost in safety data complexity?](/content/resources/are-patient-outcomes-getting-lost-in-safety-data-complexity/index.html)

- May 5, 2026

[PreviousBridging the Gap to ROI: The Power of Technology Backed by Expertise](/content/whitepapers/bridging-the-gap-to-roi/index.html)

[NextPowering the Pharmacovigilance Engine: Why AI’s Role is Pivotal Now](/content/resources/powering-the-pharmacovigilance-engine-why-ais-role-is-pivotal-now/index.html)